=== Ticker Info ===
address1	No. 1 Tung-Hsing Street
address2	Shu-Lin District
city	New Taipei City
zip	23850
country	Taiwan
phone	886 2 8684 3318
fax	886 8 6843 202
website	https://www.ccsb.com.tw
industry	Biotechnology
industryKey	biotechnology
industryDisp	Biotechnology
sector	Healthcare
sectorKey	healthcare
sectorDisp	Healthcare
longBusinessSummary	Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
companyOfficers	[{'maxAge': 1, 'name': 'Mr. Chung-Hsin  Huang', 'title': 'President & GM', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kuan-Chieh  Wang', 'title': 'Manager of Finance & Treasury Dept., and Head of Accounting & Corporate Governance', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jun-Jie  Liao', 'title': 'Manager of Human Resource Office', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chao-Sheng  Hong', 'title': 'Chief Auditor', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge	86400
priceHint	2
previousClose	46.2
open	46.2
dayLow	46.2
dayHigh	47.3
regularMarketPreviousClose	46.2
regularMarketOpen	46.2
regularMarketDayLow	46.2
regularMarketDayHigh	47.3
dividendRate	1.3
dividendYield	0.0275
exDividendDate	1690156800	 (2023-07-24 08:00:00)
payoutRatio	0.38349998
fiveYearAvgDividendYield	2.21
beta	0.733
trailingPE	13.952802
forwardPE	17.649254
volume	248297
regularMarketVolume	248297
averageVolume	285297
averageVolume10days	144082
averageDailyVolume10Day	144082
bid	47.55
ask	47.3
marketCap	3668588032
fiftyTwoWeekLow	43.6
fiftyTwoWeekHigh	101.0
priceToSalesTrailing12Months	1.7582995
fiftyDayAverage	47.849
twoHundredDayAverage	55.3175
trailingAnnualDividendRate	0.8
trailingAnnualDividendYield	0.017316017
currency	TWD
enterpriseValue	4606849024
profitMargins	0.12697
floatShares	55985135
sharesOutstanding	77560000
heldPercentInsiders	0.40914002
heldPercentInstitutions	0.01862
impliedSharesOutstanding	77643504
bookValue	43.195
priceToBook	1.0950341
lastFiscalYearEnd	1703980800	 (2023-12-31 08:00:00)
nextFiscalYearEnd	1735603200	 (2024-12-31 08:00:00)
mostRecentQuarter	1703980800	 (2023-12-31 08:00:00)
earningsQuarterlyGrowth	-0.365
netIncomeToCommon	264908992
trailingEps	3.39
forwardEps	2.68
enterpriseToRevenue	2.208
enterpriseToEbitda	9.723
52WeekChange	-0.49139786
SandP52WeekChange	0.26265144
lastDividendValue	1.3
lastDividendDate	1690156800	 (2023-07-24 08:00:00)
exchange	TAI
quoteType	EQUITY
symbol	1762.TW
underlyingSymbol	1762.TW
shortName	CHUNGHWA CHEMICAL SYNTHESIS BIO
longName	Chunghwa Chemical Synthesis & Biotech Co., Ltd.
firstTradeDateEpochUtc	1292806800	 (2010-12-20 09:00:00)
timeZoneFullName	Asia/Taipei
timeZoneShortName	CST
uuid	9588a935-52c7-3ccc-8031-67a9162f76cc
messageBoardId	finmb_42915199
gmtOffSetMilliseconds	28800000
currentPrice	47.3
recommendationMean	3.0
recommendationKey	hold
totalCash	269568992
totalCashPerShare	3.476
ebitda	473814016
totalDebt	1207830016
quickRatio	0.634
currentRatio	2.15
totalRevenue	2086440960
debtToEquity	36.052
revenuePerShare	26.901
returnOnAssets	0.03605
returnOnEquity	0.080970004
freeCashflow	-647701248
operatingCashflow	-66274000
earningsGrowth	-0.36
revenueGrowth	-0.16
grossMargins	0.36297
ebitdaMargins	0.22709
operatingMargins	0.11703
financialCurrency	TWD
trailingPegRatio	None

=== Financials ===
                                                              2023-12-31        2022-12-31        2021-12-31    2020-12-31
Tax Effect Of Unusual Items                                          0.0    3684850.849898   -3559891.391503           0.0
Tax Rate For Calcs                                              0.205639          0.200864          0.194052      0.181815
Normalized EBITDA                                            545931000.0       743721000.0       651272000.0   786208000.0
Total Unusual Items                                                  0.0        18345000.0       -18345000.0           0.0
Total Unusual Items Excluding Goodwill                               0.0        18345000.0       -18345000.0           0.0
Net Income From Continuing Operation Net Minority Interest   264909000.0       465865000.0       400778000.0   531873000.0
Reconciled Depreciation                                      193005000.0       169049000.0       131993000.0   131154000.0
Reconciled Cost Of Revenue                                  1329133000.0      1155387000.0       985314000.0   856836000.0
EBITDA                                                       545931000.0       762066000.0       632927000.0   786208000.0
EBIT                                                         352926000.0       593017000.0       500934000.0   655054000.0
Net Interest Income                                          -12168000.0        -5205000.0        -3140000.0    -4333000.0
Interest Expense                                              19439000.0         9712000.0         3321000.0     4757000.0
Interest Income                                                7271000.0         4507000.0          181000.0      424000.0
Normalized Income                                            264909000.0  451204850.849898  415563108.608497   531873000.0
Net Income From Continuing And Discontinued Operation        264909000.0       465865000.0       400778000.0   531873000.0
Total Expenses                                              1805632000.0      1671957000.0      1477882000.0  1274669000.0
Diluted Average Shares                                               NaN        78500000.0        78318000.0    78331000.0
Basic Average Shares                                                 NaN        77560000.0        77560000.0    77560000.0
Diluted EPS                                                          NaN              5.93              5.12          6.79
Basic EPS                                                            NaN              6.01              5.17          6.86
Diluted NI Availto Com Stockholders                          264909000.0       465865000.0       400778000.0   531873000.0
Net Income Common Stockholders                               264909000.0       465865000.0       400778000.0   531873000.0
Otherunder Preferred Stock Dividend                                  0.0               0.0               0.0           0.0
Net Income                                                   264909000.0       465865000.0       400778000.0   531873000.0
Minority Interests                                                   0.0         -275000.0         -272000.0     -190000.0
Net Income Including Noncontrolling Interests                264909000.0       466140000.0       401050000.0   532063000.0
Net Income Continuous Operations                             264909000.0       466140000.0       401050000.0   532063000.0
Tax Provision                                                 68578000.0       117165000.0        96563000.0   118234000.0
Pretax Income                                                333487000.0       583305000.0       497613000.0   650297000.0
Other Non Operating Income Expenses                           28340000.0        73878000.0        12178000.0   347814000.0
Special Income Charges                                               0.0        18345000.0       -18345000.0           0.0
Write Off                                                            0.0       -18345000.0        18345000.0           0.0
Net Non Operating Interest Income Expense                    -12168000.0        -5205000.0        -3140000.0    -4333000.0
Interest Expense Non Operating                                19439000.0         9712000.0         3321000.0     4757000.0
Interest Income Non Operating                                  7271000.0         4507000.0          181000.0      424000.0
Operating Income                                             280809000.0       445187000.0       456820000.0   268920000.0
Operating Expense                                            476499000.0       516570000.0       492568000.0   417833000.0
Research And Development                                     242696000.0       244789000.0       252674000.0   215729000.0
Selling General And Administration                           233803000.0       271781000.0       239894000.0   202104000.0
Selling And Marketing Expense                                129176000.0       162468000.0       144667000.0   109696000.0
General And Administrative Expense                           104627000.0       109313000.0        95227000.0    92408000.0
Gross Profit                                                 757308000.0       961757000.0       949388000.0   686753000.0
Cost Of Revenue                                             1329133000.0      1155387000.0       985314000.0   856836000.0
Total Revenue                                               2086441000.0      2117144000.0      1934702000.0  1543589000.0
Operating Revenue                                           2086441000.0      2117144000.0      1934702000.0  1543589000.0